Open AccessReduced-fluence photodynamic therapy and anti-vascular endothelial growth factor for polypoidal choroidal vasculopathy in an Indian population
Author(s) -
Parveen Sen,
Muna Bhende,
Ramya Sachidanandam,
Nishat Bansal,
Tarun Sharma
Publication year - 2016
Publication title -
indian journal of ophthalmology/indian journal of ophthalmology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.542
H-Index - 51
eISSN - 1998-3689
pISSN - 0301-4738
DOI - 10.4103/0301-4738.198856
Subject(s) - medicine , ophthalmology , visual acuity , ranibizumab , bevacizumab , retrospective cohort study , macular degeneration , vitreous hemorrhage , photodynamic therapy , surgery , chemotherapy , vitrectomy , chemistry , organic chemistry
The aim was to study the efficacy of combined therapy with reduced-fluence photodynamic therapy (RFPDT) and intravitreal bevacizumab/ranibizumab from the Indian subcontinent.